{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:24:56Z","timestamp":1794050696167,"version":"4.8.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.chest.2026.06.075","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:23:39Z","timestamp":1787984619000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Septic Shock After Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6660-099X","authenticated-orcid":false,"given":"Marielle","family":"Subileau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara","family":"Chean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamel","family":"Mokart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Platon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mayaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahema","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6050-2139","authenticated-orcid":false,"given":"Jean-Herl\u00e9","family":"Raphalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"P\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7242-0428","authenticated-orcid":false,"given":"Anne","family":"Renault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Arnales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Van De Wyngaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali\u00e9nor","family":"Xhaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naike","family":"Big\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Lafarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.chest.2026.06.075_bib1","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.3324\/haematol.2024.285002","article-title":"Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors","volume":"109","author":"Atsuta","year":"2024","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.chest.2026.06.075_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","article-title":"The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT","volume":"60","author":"Passweg","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.chest.2026.06.075_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jtct.2025.05.014","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy\u2014a report from the CIBMTR","volume":"31","author":"Spellman","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.chest.2026.06.075_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bbmt.2016.12.630","article-title":"Infectious risk after allogeneic hematopoietic cell transplantation complicated by acute graft-versus-host disease","volume":"23","author":"Miller","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.chest.2026.06.075_bib5","doi-asserted-by":"crossref","first-page":"509.e1","DOI":"10.1016\/j.jtct.2022.05.008","article-title":"Steroid-sensitive, but not steroid-dependent or steroid-resistant acute graft-versus-host disease, results in similar infection risk as no graft-versus-host disease following allogeneic hematopoietic cell transplantation","volume":"28","author":"Young","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.chest.2026.06.075_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00134-022-06676-3","article-title":"Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation","volume":"48","author":"Korell","year":"2022","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.chest.2026.06.075_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/aas.13060","article-title":"Early prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach","volume":"62","author":"Mokart","year":"2018","journal-title":"Acta Anaesthesiol Scand"},{"issue":"9","key":"10.1016\/j.chest.2026.06.075_bib8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","article-title":"Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016","volume":"95","author":"Ullmann","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.chest.2026.06.075_bib9","series-title":"The EBMT Handbook","year":"2019"},{"issue":"4","key":"10.1016\/j.chest.2026.06.075_bib10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00134-025-07865-6","article-title":"Contemporary review of critical illness following allogeneic hematopoietic stem cell transplant in adults","volume":"51","author":"Munshi","year":"2025","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.chest.2026.06.075_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bmt.2010.112","article-title":"Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated","volume":"46","author":"Poutsiaka","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.chest.2026.06.075_bib12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00134-014-3374-9","article-title":"Neutropenic cancer patients with severe sepsis: need for antibiotics in the first hour","volume":"40","author":"Mokart","year":"2014","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.chest.2026.06.075_bib13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.chest.2026.06.075_bib14","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium\u2014a Groupe de Recherche Respiratoire en R\u00e9animation Onco-H\u00e9matologique study","volume":"31","author":"Azoulay","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.chest.2026.06.075_bib15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","article-title":"Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"98","author":"Kochanek","year":"2019","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.chest.2026.06.075_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13054-024-05073-0","article-title":"Septic shock in the immunocompromised cancer patient: a narrative review","volume":"28","author":"Nates","year":"2024","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.chest.2026.06.075_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10096-021-04361-9","article-title":"Clinical outcome from hematopoietic cell transplant patients with bloodstream infection caused by carbapenem-resistant P. aeruginosa and the impact of antimicrobial combination in vitro","volume":"41","author":"Ramos","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.chest.2026.06.075_bib18","doi-asserted-by":"crossref","first-page":"310.e1","DOI":"10.1016\/j.jtct.2023.12.013","article-title":"Prognostic factors and outcomes in patients with septic shock after allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Huang","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.chest.2026.06.075_bib19","doi-asserted-by":"crossref","first-page":"114.e1","DOI":"10.1016\/j.jtct.2023.09.017","article-title":"Incidence and impact of fungal infections in post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical hematopoietic cell transplantation: a Center for International Blood and Marrow Transplant Research Analysis","volume":"30","author":"Papanicolaou","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.chest.2026.06.075_bib20","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s00277-021-04660-3","volume":"100","author":"Kimura","year":"2021","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.chest.2026.06.075_bib21","doi-asserted-by":"crossref","first-page":"E396","DOI":"10.1111\/j.1469-0691.2012.03908.x","article-title":"Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French multicentre cohort study (2003-2008)","volume":"18","author":"Xhaard","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.chest.2026.06.075_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s13054-024-05151-3","article-title":"Culture-negative sepsis may be a different entity from culture-positive sepsis: a prospective nationwide multicenter cohort study","volume":"28","author":"Chang","year":"2024","journal-title":"Crit Care"},{"issue":"15","key":"10.1016\/j.chest.2026.06.075_bib23","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/bloodadvances.2019000143","article-title":"Allogeneic reactivity\u2013mediated endothelial cell complications after HSCT: a plea for consensual definitions","volume":"3","author":"Pagliuca","year":"2019","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.chest.2026.06.075_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.beha.2008.02.003","article-title":"Vascular endothelium and graft-versus-host disease","volume":"21","author":"Biedermann","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"issue":"11","key":"10.1016\/j.chest.2026.06.075_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000005357","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2026.06.075_bib26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-015-1000-z","article-title":"Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality","volume":"19","author":"Garnacho-Montero","year":"2015","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.chest.2026.06.075_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/SHK.0000000000001553","article-title":"Aminoglycosides in immunocompromised critically ill patients with bacterial pneumonia and septic shock: a post-hoc analysis of a prospective multicenter multinational cohort","volume":"54","author":"Lopez","year":"2020","journal-title":"Shock"},{"key":"10.1016\/j.chest.2026.06.075_bib28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s13054-020-03284-9","article-title":"Aminoglycosides for the treatment of septic shock: a propensity-based study","volume":"24","author":"Llitjos","year":"2020","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.chest.2026.06.075_bib29","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on \u201csepsis-related problems\u201d of the European Society of Intensive Care Medicine","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2026.06.075_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.chest.2026.06.075_bib31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.chest.2026.06.075_bib33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.chest.2026.06.075_bib34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.chest.2026.06.075_bib36","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1164\/rccm.202401-0135OC","article-title":"Outcomes in critically ill allogeneic hematopoietic stem-cell transplantation recipients","volume":"210","author":"Lafarge","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2026.06.075_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13613-016-0202-0","article-title":"Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en R\u00e9animation Respiratoire en Onco-H\u00e9matologie (Grrr-OH) study","volume":"6","author":"Contejean","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.chest.2026.06.075_bib38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jmii.2015.01.002","article-title":"Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Liu","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.chest.2026.06.075_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.6004\/jnccn.2021.7046","article-title":"Outcomes and predictors of 28-day mortality in patients with hematologic malignancies and septic shock defined by Sepsis-3 criteria","volume":"20","author":"Manjappachar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.chest.2026.06.075_bib40","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.chest.2026.06.075_bib41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00134-019-05653-7","article-title":"Changes in critically ill cancer patients\u2019 short-term outcome over the last decades: results of systematic review with meta-analysis on individual data","volume":"45","author":"Darmon","year":"2019","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.chest.2026.06.075_bib42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bmt.2015.55","article-title":"Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients","volume":"50","author":"Lenglin\u00e9","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.chest.2026.06.075_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbmt.2012.08.012","article-title":"Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Srinivasan","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.chest.2026.06.075_bib44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/TP.0000000000001143","article-title":"Different impact of the number of organ failures and graft-versus-host disease on the outcome of allogeneic stem cell transplantation recipients requiring intensive care","volume":"101","author":"Orvain","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.chest.2026.06.075_bib45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13054-025-05486-5","article-title":"Critical care illness in allogeneic hematopoietic stem-cell transplantation recipients with chronic graft versus host disease","volume":"29","author":"Chean","year":"2025","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.chest.2026.06.075_bib46","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3324\/haematol.2016.150250","article-title":"Late effects of blood and marrow transplantation","volume":"102","author":"Inamoto","year":"2017","journal-title":"Haematologica"},{"issue":"12b","key":"10.1016\/j.chest.2026.06.075_bib47","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/imj.12595","article-title":"Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014","volume":"44","author":"Fleming","year":"2014","journal-title":"Intern Med J"},{"issue":"5","key":"10.1016\/j.chest.2026.06.075_bib48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cmi.2024.01.005","article-title":"Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"30","author":"Biyun","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.chest.2026.06.075_bib49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","article-title":"An overview of infectious complications after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Sahin","year":"2016","journal-title":"J Infect Chemother"},{"issue":"2","key":"10.1016\/j.chest.2026.06.075_bib50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00277-022-05062-9","article-title":"Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation","volume":"102","author":"Enger","year":"2023","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.chest.2026.06.075_bib51","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u03b2-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.chest.2026.06.075_bib52","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/cid\/cit565","article-title":"Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis","volume":"57","author":"Mikulska","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.chest.2026.06.075_bib53","series-title":"Antimicrobial Resistance in the EU\/EEA (EARS-Net)\u2014Annual Epidemiological Report for 2024","year":"2025"},{"issue":"1","key":"10.1016\/j.chest.2026.06.075_bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","article-title":"Survival in neutropenic patients with severe sepsis or septic shock","volume":"40","author":"Legrand","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.chest.2026.06.075_bib55","series-title":"Impact of aminoglycosides-based antibiotics combination and protective isolation on outcomes in critically-ill neutropenic patients with sepsis: a randomized 2 by 2 factorial design randomized pragmatic trial","year":"2022"},{"issue":"11","key":"10.1016\/j.chest.2026.06.075_bib56","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00277-021-04640-7","article-title":"Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study","volume":"100","author":"Gournay","year":"2021","journal-title":"Ann Hematol"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922606486X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922606486X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:34:39Z","timestamp":1794047679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236922606486X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"alternative-id":["S001236922606486X"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2026.06.075","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Septic Shock After Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2026.06.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}